 SOUTH SAN FRANCISCO, Calif., Oct. 07, 2021 GLOBE NEWSWIRE -- ALX Oncology Holdings Inc. ALX Oncology Nasdaq: ALXO, a clinical-stage immuno-oncology company, and ScalmiBio, Inc. ScalmiBio announced today that ALX Oncology has acquired ScalmiBio. 